公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2022 | Chimeric immune checkpoint protein vaccines inhibit the tumorigenesis and growth of rat cholangiocarcinoma | Pan, Yi-Ru; Wu, Chiao-En; Huang, Wen-Kuan; Chen, Ming-Huang; KENG-HSUEH LAN ; Yeh, Chun-Nan | Frontiers in immunology | 2 | 2 | |
2019 | An open label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy and safety of TLC388 as second-line treatment in subjects with poorly differentiated neuroendocrine carcinomas (TCOGT1Z14). | Chen, Ming-Huang; Chou, Wen-Chi; Hsiao, Chin-Fu; Liu, Yi-Chang; Hsu, Chiun; Yanshen, Shan; Hung, Yi-Ping; Hsieh, Chia-Hsun; Chiu, Chao-Hua; Liu, Ta-Chih; Cho, Shih-Feng; Liu, Tsang-Wu; Chao, Yee; YI-PING HUNG | Journal of Clinical Oncology | 0 | 0 | |
2017 | A phase II trial of regorafenib in patients with metastatic and/ or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17 | Yeh, Chun-Nan; Chen, Ming-Huang; Chen, Yen-Yang; CHING-YAO YANG ; Yen, Chueh-Chuan; Tzen, Chin-Yuan; Chen, Li-Tzong; YEN-YANG CHEN | Oncotarget | 47 | 43 | |
2016 | 超音波對比劑聲學反應之優化 | 陳明煌; Chen, Ming-Huang | 0 | 0 |